Primary Site >> Liver Cancer
Gene >> CTLA4
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer. PMID: 20538028 Ref: [Association of CTLA4 gene +49G/A polymorphism with HBV infection and HBV-related hepatocellular carcinoma in Hunan Han population]. PMID: 20813679 |
Ref: Hepatocellular carcinoma from an immunologic perspective. PMID: 24030702 |
Ref: Relating the outcome of HCV infection and different host SNP polymorphisms in a Majorcan population coinfected with HCV-HIV and treated with pegIFN-RBV. PMID: 25296442 |
Ref: Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells. PMID: 26639061 |
Ref: Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. PMID: 27816492 Ref: Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. PMID: 28648905 Ref: Therapeutic vaccine to cure large mouse hepatocellular carcinomas. PMID: 28881713 |
Ref: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review). PMID: 29786110 Ref: Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer. PMID: 29900067 Ref: [Liver injury induced by immune checkpoint inhibitor-therapy : Example of an immune-mediated drug side effect]. PMID: 30310977 |